The proposed sale is small relative to Viatris's market cap and relates to shares acquired through compensation vesting, not open-market accumulation being unwound. This is likely a routine liquidity event. Monitor for actual execution on Form 4 filings, but the 144 alone does not warrant a directional trade.
VTRS drugs
VTRS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 26 $16.33entry
- T+1 · 5mo ago −0.61%α −2.26% · $16.23
- T+5 · 4mo ago +2.27%α +0.10% · $16.70
- T+20 · 4mo ago +5.82%α +4.56% · $17.28
- T+60 · 8w ago +4.72%α −1.39% · $17.10
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Viatris officer Paul Campbell filed a Form 144 notice of intent to sell 50,076 shares of common stock, with an approximate market value of $809,678 based on the filing date. The shares being sold were acquired through vesting of stock awards in March 2023 and March 2024, suggesting routine portfolio diversification rather than a discretionary bearish signal.
Key Facts
- Form 144 filed June 25, 2026 by officer Paul Campbell for the sale of 50,076 shares.
- Estimated dollar value of proposed sale: $809,677.94 at approximately $16.17/share.
- Shares were acquired via vesting of stock awards on 03/04/2023 (361 shares) and 03/02/2024 (49,715 shares) as compensatory payments.
- Broker for the proposed sale is Merrill Lynch.
- Viatris has a market cap of $18.6B with 67% analyst bullish rating.
Financial Impact
Proposed sale of 50,076 shares (~$810K) represents about 0.004% of Viatris's $18.6B market cap, de minimis.
Risk Factors
- Form 144 is a notice of intent, the sale may not be executed, but its filing signals the insider considered selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-045540 |
| Document: 0001628280-26-045540-index.html | 0001628280-26-045540 |
| Document: 0001628280-26-045540.txt | 0001628280-26-045540 |
Track record
22 reports on VTRS
3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +16.85% at T+60 after the Aug 6, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 17, 2026today 8-K Neutral 4/10 Entry $20.51 Now $20.49 −0.10% settles Feb 16
- Nov 17, 2026today Press Release Neutral 4/10 Entry $20.89 Now $20.49 −1.91% settles Feb 16
- Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $20.84 Now $20.49 −1.68% settles Feb 12
- Nov 6, 202611d ago SC 13G/A Neutral 2/10 Entry $19.91 Now $20.49 +2.91% settles Feb 4
- Nov 5, 202612d ago 8-K Mixed 6/10 Entry $18.97 Now $20.49 +8.01% settles Feb 3
- Nov 4, 202613d ago Press Release Neutral 2/10 Entry $19.22 Now $20.49 +6.61% settles Feb 2
- Oct 30, 202618d ago Press Release Bullish 6/10 Entry $19.04 Now $20.49 +7.64% settles Jan 28
- Oct 29, 202619d ago Institutional Cluster Bullish 4/10 Entry $19.20 Now $20.49 +6.72% settles Jan 27
- Oct 16, 20264w ago Press Release Bullish 6/10 Entry $18.26 Now $20.49 +12.21% settles Jan 14
- Oct 8, 20265w ago 8-K Bullish 7/10 Entry $17.44 Now $20.49 +17.49% settles Jan 5
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers